Skip to main content

4 Result(s)

within English Remove this filter Medicine & Public Health Remove this filter Cancer Research Remove this filter A. Fabbri Remove this filter Article Remove this filter

and

  1. No Access

    Article

    Reply to Rituximab activity in CD20 positive multiple myeloma

    A Gozzetti, A Fabbri, S Lazzi, M Bocchia, F Lauria in Leukemia (2007)

  2. No Access

    Article

    Reply to ‘Rituximab activity in CD20-positive multiple myeloma’

    A Gozzetti, A Fabbri, S Lazzi, M Bocchia, F Lauria in Leukemia (2008)

  3. No Access

    Article

    First-line chemotherapy with planned sequential administration of cisplatin/gemcitabine followed by docetaxel in elderly ‘unfrail’ patients with advanced non-small-cell lung cancer: a multicenter phase II study

    The role of cisplatin in the first-line treatment for elderly advanced non-small-cell lung cancer is not completely defined. We previously reported in this subset of patients an interesting efficacy and tolera...

    C. Tibaldi, A. Camerini, A. D’Incecco… in Journal of Cancer Research and Clinical On… (2012)

  4. No Access

    Article

    Impact of previous corticosteroid exposure on outcomes of patients receiving immune checkpoint inhibitors for advanced non-small cell lung cancer: a retrospective observational study

    Immunosuppressive dosing of corticosteroids at the start of treatment impairs immune checkpoint inhibitor (ICI) efficacy in advanced non-small cell lung cancer (NSCLC). Previous cumulative dose and intake moda...

    F. Nelli, A. Virtuoso, J. R. Giron Berrios… in Cancer Chemotherapy and Pharmacology (2022)